Join us in-person for the 2025 DTRF "Together We Will" Weekend in Chicago from Sept. 12-13! - Register Today

May 2024

Building the Evidence for Systemic Treatment in Desmoid Fibromatosis: Is a New Metronomic Regimen Another Layer in the Foundation?

Author Information

Thierry Alcindor 1

1Center for Sarcoma, Center for Global Cancer Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Publication

JCO Glob Oncol

Summary

Thalcin explains how a metronomic regimen for desmoid tumors fits in the current treatment landscape.